Century Therapeutics, Inc. (IPSC) has 20 알려진 내부자 및 기관 보유자 기록. 최대 보유자는 Versant Venture Capital VI, L.P. 11,452,014 주 보유. 기타 주요 보유자에는 Versant Vantage II GP-GP, LLC 및 Pfeiffenberger Brent.
지난 12개월간 내부자는 45 건의 거래를 수행 IPSC 주식 — 17 건 매수 (평가액 $3.46M) 및 20 건 매도 (평가액 $85.18K). 내부자 매도가 매수를 초과했습니다.
IPSC 내부자 보유 현황
최대 보유자
Versant Venture Capital VI, L.P.
11,452,014 주
내부자 주요 보유자
| # |
이름 |
직책 |
보유 주식수 |
최종 신고일 |
상대적 규모 |
| 1 |
Versant Venture Capital Vi, L.p. |
10 Percent Owner |
11,452,014 |
2022-08-11 |
|
| 2 |
Versant Vantage Ii Gp-gp, Llc |
Director |
11,452,014 |
2022-08-11 |
|
| 3 |
Pfeiffenberger Brent |
President and CEO |
3,710,958 |
2026-03-13 |
|
| 4 |
Cowan Chad |
Chief Scientific Officer |
1,175,680 |
2026-04-03 |
|
| 5 |
Flores Osvaldo |
Chief Executive Officer |
637,500 |
2023-02-06 |
|
| 6 |
Russotti Gregory |
See Remarks |
515,427 |
2026-03-16 |
|
| 7 |
Carr Douglas |
SVP Finance & Operations |
507,261 |
2026-03-16 |
|
| 8 |
Diem Michael Craig |
Chief Financial Officer |
253,533 |
2023-11-03 |
|
| 9 |
Farid Adrienne |
Chief Operations Officer |
250,141 |
2025-06-11 |
|
| 10 |
Lee Han Myung |
Director |
88,000 |
2025-12-11 |
|
| 11 |
Carlo Rizzuto |
Director |
44,000 |
2025-06-16 |
|
| 12 |
Jimenez Joseph |
Director |
44,000 |
2025-06-16 |
|
| 13 |
Riva Alessandro |
Director |
44,000 |
2025-06-16 |
|
| 14 |
Blackwell Kimberly |
Director |
44,000 |
2025-06-16 |
|
| 15 |
Butitta Cynthia M |
Director |
44,000 |
2025-06-16 |
|
| 16 |
Quimi Daphne |
Director |
44,000 |
2025-06-16 |
|
| 17 |
Walbert Timothy P |
Director |
44,000 |
2025-06-16 |
|
| 18 |
Borges Luis |
Chief Scientific Officer |
43,750 |
2023-03-23 |
|
| 19 |
Levitsky Hyam |
President of R&d |
24,000 |
2024-03-11 |
|
| 20 |
Casdin Eli |
Director |
19,872 |
2022-06-10 |
|
최근 거래 (최근 12개월)
| 날짜 |
이름 |
직책 |
유형 |
주식수 |
주가 |
금액 |
| 2026-04-01 |
Cowan Chad |
Chief Scientific Officer |
RSU 원천징수 |
1,365 |
$2.19 |
$2.99K |
| 2026-03-12 |
Russotti Gregory |
See Remarks |
정보 매도 |
10,076 |
$2.55 |
$25.68K |
| 2026-03-12 |
Carr Douglas |
SVP Finance & Operations |
정보 매도 |
7,043 |
$2.55 |
$17.95K |
| 2026-03-11 |
Cowan Chad |
Chief Scientific Officer |
RSU 원천징수 |
1,431 |
$2.73 |
$3.91K |
| 2026-03-11 |
Pfeiffenberger Brent |
President and CEO |
RSU 원천징수 |
55,397 |
$2.73 |
$151.23K |
| 2026-03-09 |
Russotti Gregory |
See Remarks |
정보 매도 |
479 |
$2.54 |
$1.21K |
| 2026-03-06 |
Pfeiffenberger Brent |
President and CEO |
RSU 원천징수 |
463 |
$2.56 |
$1.19K |
| 2026-02-13 |
Pfeiffenberger Brent |
President and CEO |
RSU 원천징수 |
31,172 |
$1.75 |
$54.55K |
| 2026-02-03 |
Carr Douglas |
SVP Finance & Operations |
정보 매도 |
323 |
$1.82 |
$588.51 |
| 2026-02-02 |
Cowan Chad |
Chief Scientific Officer |
RSU 부여 |
265,000 |
$1.84 |
$487.6K |
| 2026-02-02 |
Pfeiffenberger Brent |
President and CEO |
RSU 부여 |
945,000 |
$1.84 |
$1.74M |
| 2026-02-02 |
Russotti Gregory |
See Remarks |
RSU 부여 |
265,000 |
$1.84 |
$487.6K |
| 2026-02-02 |
Carr Douglas |
SVP Finance & Operations |
RSU 부여 |
225,000 |
$1.84 |
$414K |
| 2026-01-02 |
Cowan Chad |
Chief Scientific Officer |
RSU 원천징수 |
1,611 |
$1.00 |
$1.6K |
| 2025-12-22 |
Cowan Chad |
Chief Scientific Officer |
정보 매수 |
58,060 |
$0.85 |
$49.25K |
| 2025-12-12 |
Pfeiffenberger Brent |
President and CEO |
정보 매수 |
52,000 |
$0.58 |
$30.35K |
| 2025-12-10 |
Pfeiffenberger Brent |
President and CEO |
RSU 원천징수 |
463 |
$0.53 |
$243.54 |
| 2025-12-09 |
Lee Han Myung |
Director |
RSU 부여 |
88,000 |
$0.59 |
$52.1K |
| 2025-12-09 |
Lee Han Myung |
Officer |
알 수 없음 |
- |
- |
- |
| 2025-12-08 |
Russotti Gregory |
See Remarks |
정보 매도 |
526 |
$0.53 |
$279.83 |
| 2025-12-08 |
Carr Douglas |
SVP Finance & Operations |
정보 매도 |
257 |
$0.53 |
$136.72 |
| 2025-11-20 |
Cowan Chad |
Chief Scientific Officer |
정보 매도 |
5,462 |
$0.50 |
$2.74K |
| 2025-11-19 |
Pfeiffenberger Brent |
President and CEO |
정보 매수 |
35,000 |
$0.50 |
$17.33K |
| 2025-11-17 |
Pfeiffenberger Brent |
President and CEO |
정보 매도 |
32,456 |
$0.45 |
$14.74K |
| 2025-11-03 |
Carr Douglas |
SVP Finance & Operations |
정보 매도 |
292 |
$0.59 |
$171.11 |
